Immune Therapeutics, Inc. to Hold an Informational Shareholder Meeting on Wednesday, August 17, 2016 at 10 A.M. EDT
July 26 2016 - 2:17PM
Marketwired
Immune Therapeutics, Inc. to Hold an Informational Shareholder
Meeting on Wednesday, August 17, 2016 at 10 A.M. EDT
ORLANDO, FL-(Marketwired - Jul 26, 2016) - Immune Therapeutics,
Inc. (OTCQB: IMUN) An Informational Shareholder Meeting will be
held on Wednesday, August 17, 2016, at 10 a.m. EDT, at the Citrus
Club, 255 South Orange Avenue, Suite 1800, Orlando, FL 32801.
An archive of the Informational Shareholder Meeting will be
available on the Immune Therapeutics' website by Monday, August 22,
2016 at www.immunetherapeutics.com.
In order to attend the Shareholder Meeting you must be a
shareholder of record or a beneficial owner of Immune Therapeutics,
Inc. stock as of the close of business on August 16, 2016.
The meeting is for shareholders only.
About Immune Therapeutics:
Immune Therapeutics, formerly known as TNI BioTech, Inc., is a
biotechnology company working to combat chronic, life-threatening
diseases through the activation and modulation of the body's immune
system using its patented immunotherapy. Its products and
immunotherapy technologies are designed to harness the power of the
immune system to improve the treatment of cancer, infections such
as HIV/AIDS, chronic inflammatory diseases, and autoimmune
diseases.
Immune Therapeutics' proprietary technology, therapies and
patents include the treatment of a wide range of cancers. Its most
advanced clinical programs involve immunotherapy with
met-enkephalin (MENK) (sometimes referred to as opioid growth
factor) and its Low Dose Naltrexone (LDN) product or Lodonal, which
have been shown to stimulate the immune system even in patients
with advanced cancer.
ContactAmato and Partners, LLCInvestor Relations Counsel90 Park
Avenue. 17th FloorNew York, NY 10016admin@amatoandpartners.com
Immune Therapeutics (PK) (USOTC:IMUN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Immune Therapeutics (PK) (USOTC:IMUN)
Historical Stock Chart
From Apr 2023 to Apr 2024